Invariant Natural Killer T Cells in Cancer Immunotherapy: Lipid-Based Modulation, Nanotechnology, and Translational Advances. [PDF]
Aloliqi AA +4 more
europepmc +1 more source
Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia. [PDF]
Li YR +6 more
europepmc +1 more source
FOXP3-activated KCNMB2-AS1 promotes clear cell renal cell carcinoma through the miR-744-3p/CD1D axis. [PDF]
Huang G, Gui D, Guo Y, Luo S, Xu Z.
europepmc +1 more source
Innate-like T Cell Biology in the Tumor Microenvironment Implications for Cancer Immunotherapy. [PDF]
Sanjari Pour M, Nasimian A, Kazi JU.
europepmc +1 more source
Detergents alter the stability and lipid binding properties of the CD1d immunoreceptor. [PDF]
Miles UZ, Finn MG, McShan AC.
europepmc +1 more source
CAR-iNKT cells for cancer therapy: a comprehensive review of engineering, mechanisms, and clinical progress. [PDF]
Yang Y, Gu J, Ding Y, Li Y, Sun Z.
europepmc +1 more source
Harnessing Vδ1<sup>+</sup> T cells for next-generation immunotherapy: from mechanistic insights to clinical translation. [PDF]
Wang F, Zhao J, Zhang T, Shi J.
europepmc +1 more source
Invariant and Diverse NKT Cells Regulate Bacterial Clearance and Pathology in Chlamydial Genital Tract Infection in Mice. [PDF]
Ishii K +10 more
europepmc +1 more source
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural Mesothelioma. [PDF]
Li YR +13 more
europepmc +1 more source

